Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
about
Anti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaINTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONSProtocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trialsIntravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.Use of antivascular endothelial growth factor for diabetic macular edema.The multifactorial nature of retinal vascular diseaseNovel Pharmacologic Approaches for the Management of Diabetic RetinopathyThe effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy.Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review.Pathophysiology and treatment of diabetic retinopathy.Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Association of systemic comorbidity in diabetic serous macular detachment and comparison of various combination therapies in its management.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study.Current treatments in diabetic macular oedema: systematic review and meta-analysisVitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.Evolving strategies in the management of diabetic retinopathyComparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema.On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.Treatment of diabetic retinopathy with anti-VEGF drugs.The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases.Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month rStrategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.Nine-month results of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular oedema: a retrospective analysis.Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population.Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy.Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy.Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
P2860
Q24193083-67C58F50-20F5-4708-9B93-A47FF2CBD84EQ24202071-C3F5A9DE-96D5-475A-87DE-49DF29B5F72BQ24240165-B8F635A0-4ED2-4D13-A932-B365863C4C54Q26782198-FF00C58B-D2F4-40A0-8C49-108C1144C144Q28680651-994FFD91-2AC3-42FC-B4FD-E1091B119888Q33542959-2D8B39B5-39F5-456F-9A3D-8B8B6730F31BQ33599732-86F51DA1-C182-4C46-AF48-7DAC8BF69A2EQ33660130-53E06A69-BA17-47AF-B4C0-81E9E72F172EQ33751308-AD35D9B4-A31A-4C41-B7CA-A78E60B40272Q33769452-47FE02A1-3AA8-4B6C-BDCA-5D9A678E701AQ33996047-38410233-620A-45FC-A6D4-9E69161E55A0Q34378757-CD23DEE2-AA7E-4A07-A16B-E5DAC706F38AQ34528134-3CC81149-D99A-4732-9A43-10A44BD84D5CQ34558187-186CD1F2-40A0-489E-B6FF-9A8577B38978Q34560674-BA6B0B31-D6A9-4136-B401-0350B50ACC32Q34601246-871CB738-C695-416A-827B-BFEA0B06546BQ34606190-6C17C5C2-1BCC-46E9-9465-9A82F70DEA4DQ34752779-8D21A702-1429-4449-B335-0962D2D82BC1Q35009731-B0C78626-8904-46AB-9A45-4F7A9D81FF99Q35067102-F72FDECC-6CFD-4FDC-A095-9E15F9BC03BFQ35691932-5BE16706-B527-477B-8E26-EB34D772C6F5Q36056409-41F589B9-2DC2-477A-A1F7-76A4804A6AABQ37126900-25389A93-3B6E-4568-BA74-0A7A4E39B1FDQ37468754-560480BA-56BB-4003-8590-832EF1100532Q37474648-72EB022B-E191-447C-B8FF-CE0AC2063D6CQ37776162-DA645E0B-48F7-46A3-BF24-F6F9B275C9FFQ37806321-C0DE4567-0A50-4540-9840-360A11253F05Q38242801-51694A59-C0DE-4EB7-825F-FA1B6B28CCC7Q38731129-F4387594-52CD-4F79-9356-93AD80051EABQ41393449-2DDED2A9-0865-47A7-8B35-2AAD04BDA530Q44214622-8F8CC7C5-B257-4900-8504-8D6567B2B0A4Q45231834-C32ABB6B-539F-4426-A608-ECE3F2CF6122Q47108294-95AB6713-48BC-4BCF-8E02-62DD6FA8DAEBQ51628940-2C600766-A269-4F83-BF72-4604730C0AB8Q52609620-A0A6B9AD-3160-4CD7-9264-AC665E4397B2Q53511112-A64F7065-9074-4F27-B367-BEC51EB0BAC5
P2860
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intravitreal triamcinolone ver ...... macular oedema (IBEME study).
@en
type
label
Intravitreal triamcinolone ver ...... macular oedema (IBEME study).
@en
prefLabel
Intravitreal triamcinolone ver ...... macular oedema (IBEME study).
@en
P2093
P356
P1476
Intravitreal triamcinolone ver ...... c macular oedema (IBEME study)
@en
P2093
J C Barbosa
M S Folgosa
P356
10.1136/BJO.2007.129122
P407
P577
2007-10-26T00:00:00Z